YNBY International Ltd. (0030.HK)
ValueMarkers Composite Index
DCF data not available
YNBY International Ltd. (0030.HK) — VMCI valuation read
YNBY International Ltd. sits at VMCI 45/100, with the Financial Services sector median at 50. That 5-point spread is the first thing to note on 0030.HK: it tells the reader the composite is unfavorable before any single ratio is examined, and the mid-cap tier sets the comparison set.
Form 4 disclosures on 0030.HK are blank for the trailing 30 days. With the insider channel offline, the EV/EBITDA delta, free-cash-flow trajectory, and the next earnings print do the talking.
**Investor frame.** The Value read on 0030.HK: 0030.HK trades at 24.0x earnings, 33% above the Financial Services median of 18.0x, with EV/EBITDA at 13.0x against 12.0x. The Quality read: ROIC of 8.0% trails the Financial Services median (10.0%) by 2.0pp. The Risk read: net debt to EBITDA of -0.8x leaves covenant headroom, anchoring the bear scenario on a measurable balance-sheet metric.
0030.HK fell 3.1% over the trailing 7 days, with a +1.2% read on a 30-day basis.
YNBY International Ltd., an investment holding company, engages in the money lending, and trading of goods and commodities in Hong Kong, the People's Republic of China, and internationally. The company operates through Money Lending; Trading of Goods and Commodities; and Cannabidiol (CBD) isolate segments. It provides short-term personal and corporate loans; and trades in refined edible oil, sugar, cosmetic, cannabidiol, and personal care products. Ban Loong Holdings Limited has a strategic cooperation agreement with Alpex Pharma SA to cooperate on the development and commercialization of nutraceutical products. The company was formerly known as ABC Communications (Holdings) Limited and changed its name to Ban Loong Holdings Limited in October 2015. Ban Loong Holdings Limited is based in Wan Chai, Hong Kong.
Related Stocks in Financial Services
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.